Tofacitinib, 250 mg

Tofacitinib is a structurally characterized compound, identified as a kinase inhibitor, with a molecular formula of C28H34F3N6O3S and a molecular weight of 597.64 g/mol. This compound is available as a 250 mg pure solid in a sealed container, making it suitable for various pharmaceutical applications. Tofacitinib exhibits selective inhibition of Janus kinases JAK1, JAK2, JAK3, and TYK2, which play a key role in inflammatory responses and immune system regulation. It has been approved for the treatment of rheumatoid arthritis and ulcerative colitis due to its potent immunosuppressive effects. Additionally, Tofacitinib demonstrates oral bioavailability and good solubility in aqueous solutions, contributing to its efficacy as an oral medication.

• CAS Number: 477600-75-2